Search research articles
Contact Us
Filters
Showing results (91-100 of 144) with videos related to
Page
of 15
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 16, 2010
Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro
A Wirsing, K A Johnstone, L W Harries, et al.
Human Mutation
|
October 1, 2003
Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY)
K L Thomson, A L Gloyn, K Colclough, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 20, 2015
Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort
S Bacon, M P Kyithar, S R Rizvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2007
Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation
T Vu, S Ellard, C H Speers, et al.
Diabetologia
|
April 11, 2002
Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes
A L Gloyn, S Ellard, J P Shield, et al.
Neurology
|
July 27, 2007
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain
K Shimomura, F Hörster, H de Wet, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
March 12, 2014
Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism
Suresh Chandran, Fabian Yap Kok Peng, Victor Samuel Rajadurai, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 27, 2001
Predictive genetic testing in maturity-onset diabetes of the young (MODY)
M Shepherd, I Ellis, A M Ahmad, et al.
Gynecologic Oncology
|
May 16, 2013
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
A V Tinker, S Ellard, S Welch, et al.
Diabetologia
|
March 13, 2008
A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications
P Tammaro, S E Flanagan, B Zadek, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 144) with videos related to
Sort By:
Page
of 15
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 16, 2010
Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro
A Wirsing, K A Johnstone, L W Harries, et al.
Human Mutation
|
October 1, 2003
Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY)
K L Thomson, A L Gloyn, K Colclough, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 20, 2015
Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort
S Bacon, M P Kyithar, S R Rizvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2007
Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation
T Vu, S Ellard, C H Speers, et al.
Diabetologia
|
April 11, 2002
Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes
A L Gloyn, S Ellard, J P Shield, et al.
Neurology
|
July 27, 2007
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain
K Shimomura, F Hörster, H de Wet, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
March 12, 2014
Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism
Suresh Chandran, Fabian Yap Kok Peng, Victor Samuel Rajadurai, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 27, 2001
Predictive genetic testing in maturity-onset diabetes of the young (MODY)
M Shepherd, I Ellis, A M Ahmad, et al.
Gynecologic Oncology
|
May 16, 2013
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
A V Tinker, S Ellard, S Welch, et al.
Diabetologia
|
March 13, 2008
A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications
P Tammaro, S E Flanagan, B Zadek, et al.
Page
of 15